US equities |
MU $896.07 ▼-0.98% NVDA $216.47 ▼-0.29% SPCX $147.79 ▼-0.11% AAPL $339.50 ▼-1.00% META $693.94 ▼-1.63% TSLA $373.71 ▲+1.54% AMZN $262.63 ▲+0.07% SNDK $1,365.38 ▼-0.42%
FinancialContent

Latest News about Michael Mullette

Recent news which mentions Michael Mullette

Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Tickers CMPS NEWS
Tags Psychedelics Lykos Therapeutics FDA
From Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Tickers AWKNF
Tags Michael Mullette Nick Kadysh Courtney Barnes
From Benzinga
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
Tickers MAPS
Tags Maps psychedelics Michael Mullette
From Benzinga